Edition:
India

People: Amneal Pharmaceuticals Inc (AMRX.N)

AMRX.N on New York Stock Exchange

3.87USD
9:00pm IST
Change (% chg)

$0.05 (+1.31%)
Prev Close
$3.82
Open
$3.76
Day's High
$3.99
Day's Low
$3.76
Volume
52,258
Avg. Vol
308,399
52-wk High
$5.78
52-wk Low
$2.40

George, Jeffrey 

Mr. Jeffrey (Jeff) P. George serves as Independent Director of the Company. Jeff George has nearly 20 years of global healthcare and corporate leadership experience. He is currently the Managing Partner of Maytal Capital, a healthcare-focused private equity investment and advisory firm he founded, and an Operating Partner at Revival Healthcare Capital, a medical device-focused private equity firm. Between 2008 and 2016, he served on the Executive Committee of Novartis Group AG, one of the largest global pharmaceutical companies, first as Division Head and CEO of Sandoz, Novartis’ $10 billion generic pharmaceuticals and biosimilars subsidiary, and then as Division Head and CEO of Alcon, Novartis’ then $10 billion branded eye care subsidiary. In both roles, he was responsible for leading over 25,000 associates globally across more than 160 countries. More recently, he served as CEO and board member of Performance Health, the largest global manufacturer and distributor of products to the physical therapy and rehabilitation markets.

Basic Compensation

Total Annual Compensation, USD --
Restricted Stock Award, USD 35,805
Long-Term Incentive Plans, USD --
All Other, USD 76,358
Fiscal Year Total, USD 112,163

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --